Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial

Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:46:49.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the keyword 'Interstitial lung disease 2' from the page metadata/keywords.
    Difference
    0.1%
    Check dated 2026-03-26T11:29:42.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Site version updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:16:15.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:49:27.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Pulmonary fibrosis was added to the Keywords/MeSH terms to better reflect the studied condition and improve indexing.
    Difference
    0.1%
    Check dated 2026-02-25T18:44:59.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2 and the earlier v3.4.1 funding/operational notice was removed. No study-related content, eligibility criteria, or results were changed.
    Difference
    0.5%
    Check dated 2026-02-11T12:27:07.000Z thumbnail image

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.